Works by Ochi, Hironori

Results: 104

Use of traction table did not increase complications in total hip arthroplasty through direct anterior approach performed by novice surgeon.

Published in:

2020

By:

Sammy Banno;
Tomonori Baba;
Hiroki Tanabe;
Yasuhiro Homma;
Hironori Ochi;
Taiji Watari;
Hideo Kobayashi;
Kazuo Kaneko;
Banno, Sammy;
Baba, Tomonori;
Tanabe, Hiroki;
Homma, Yasuhiro;
Ochi, Hironori;
Watari, Taiji;
Kobayashi, Hideo;
Kaneko, Kazuo

Publication type:

journal article

Impact of muscle volume changes following atezolizumab‐bevacizumab therapy in patients with unresectable hepatocellular carcinoma.

Published in:

Hepatology Research, 2025, v. 55, n. 7, p. 1046, doi. 10.1111/hepr.14201

By:

Ochi, Hironori;
Tani, Joji;
Tomonari, Tetsu;
Tanaka, Hironori;
Imai, Yusuke;
Tanaka, Takaaki;
Ohama, Hideko;
Tada, Fujimasa;
Hiraoka, Atsushi;
Hirose, Akira;
Ogawa, Chikara;
Morishita, Asahiro;
Moriya, Akio;
Nakamura, Yoshiko;
Hirooka, Masashi;
Deguchi, Akihiro

Publication type:

Article

Importance of screening for synchronous malignant neoplasms in patients with hepatocellular carcinoma: impact of FDG PET/ CT.

Published in:

Liver International, 2013, v. 33, n. 7, p. 1085, doi. 10.1111/liv.12161

By:

Hiraoka, Atsushi;
Hirooka, Masashi;
Ochi, Hironori;
Koizumi, Yohei;
Shimizu, Yuko;
Shiraishi, Akiko;
Yamago, Hiroka;
Tanihira, Tetsuya;
Miyata, Hideki;
Ninomiya, Tomoyuki;
Kawasaki, Hideki;
Ishimaru, Yoshihiro;
Sogabe, Ichiro;
Inoue, Takeshi;
Abe, Masanori;
Hiasa, Yoichi;
Matsuura, Bunzo;
Onji, Morikazu;
Michitaka, Kojiro

Publication type:

Article

Lenvatinib as Second-Line Treatment after Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma: Clinical Results Show Importance of Hepatic Reserve Function.

Published in:

Oncology, 2023, v. 101, n. 10, p. 624, doi. 10.1159/000531316

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

Comparison between Atezolizumab Plus Bevacizumab and Lenvatinib for Hepatocellular Carcinoma in Patients with Child-Pugh Class B in Real-World Clinical Settings.

Published in:

Oncology, 2023, v. 101, n. 9, p. 542, doi. 10.1159/000530028

By:

Ohama, Hideko;
Hiraoka, Atsushi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

Nutritional Status Is Associated with Prognosis in Patients with Advanced Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab.

Published in:

Oncology, 2023, v. 101, n. 4, p. 270, doi. 10.1159/000527676

By:

Tada, Toshifumi;
Kumada, Takashi;
Hiraoka, Atsushi;
Kariyama, Kazuya;
Tani, Joji;
Hirooka, Masashi;
Takaguchi, Koichi;
Atsukawa, Masanori;
Fukunishi, Shinya;
Itobayashi, Ei;
Tsuji, Kunihiko;
Tajiri, Kazuto;
Ochi, Hironori;
Ishikawa, Toru;
Yasuda, Satoshi;
Ogawa, Chikara;
Toyoda, Hidenori;
Hatanaka, Takeshi;
Nishimura, Takashi;
Kakizaki, Satoru

Publication type:

Article

Clinical Predictor of Urinary Protein as Adverse Event Associated with Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma.

Published in:

Oncology, 2022, v. 100, n. 12, p. 645, doi. 10.1159/000526521

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

Impact of Early Lenvatinib Administration on Survival in Patients with Intermediate-Stage Hepatocellular Carcinoma: A Multicenter, Inverse Probability Weighting Analysis.

Published in:

Oncology, 2021, v. 99, n. 8, p. 518, doi. 10.1159/000515896

By:

Tada, Toshifumi;
Kumada, Takashi;
Hiraoka, Atsushi;
Michitaka, Kojiro;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Fukunishi, Shinya;
Ohama, Hideko;
Kawata, Kazuhito

Publication type:

Article

Nutritional Index as Prognostic Indicator in Patients Receiving Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma.

Published in:

Oncology, 2020, v. 98, n. 5, p. 295, doi. 10.1159/000506293

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Tada, Toshifumi;
Fukunishi, Shinya;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Kawata, Kazuhito;
Toyoda, Hidenori;
Ohama, Hideko;
Tsutsui, Akemi;
Itokawa, Norio

Publication type:

Article

Early Relative Change in Hepatic Function with Lenvatinib for Unresectable Hepatocellular Carcinoma.

Published in:

Oncology, 2019, v. 97, n. 6, p. 334, doi. 10.1159/000502095

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Tada, Toshifumi;
Toyoda, Hidenori;
Nouso, Kazuhiro;
Tsutsui, Akemi;
Nagano, Takuya;
Itokawa, Norio;
Hayama, Korenobu

Publication type:

Article

Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma.

Published in:

Oncology, 2019, v. 97, n. 5, p. 277, doi. 10.1159/000501281

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Tada, Toshifumi;
Toyoda, Hidenori;
Nouso, Kazuhiro;
Tsutsui, Akemi;
Nagano, Takuya;
Itokawa, Norio;
Hayama, Korenobu

Publication type:

Article

Combination of Resection and Ablative Treatment for Hepatocellular Carcinoma: Usefulness of Complementary Radiofrequency Ablation.

Published in:

Oncology, 2019, v. 96, n. 5, p. 242, doi. 10.1159/000496225

By:

Hiraoka, Atsushi;
Hirooka, Masashi;
Ochi, Hironori;
Koizumi, Yohei;
Izumoto, Hirofumi;
Ueki, Hidetaro;
Tsuruta, Miho;
Ono, Atsushi;
Yoshino, Takeaki;
Aibiki, Toshihiko;
Okudaira, Tomonari;
Yamago, Hiroka;
Suga, Yoshifumi;
Iwasaki, Ryuichiro;
Mori, Kenichiro;
Miyata, Hideki;
Kishida, Masato;
Tsubouchi, Eiji;
Abe, Masanori;
Matsuura, Bunzo

Publication type:

Article

Relationship of Atezolizumab plus Bevacizumab Treatment with Muscle Volume Loss in Unresectable Hepatocellular Carcinoma Patients: Multicenter Analysis.

Published in:

Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 209, doi. 10.1159/000527402

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

What Can Be Done to Solve the Unmet Clinical Need of Hepatocellular Carcinoma Patients following Lenvatinib Failure?

Published in:

Liver Cancer (2235-1795), 2021, v. 10, n. 2, p. 115, doi. 10.1159/000513355

By:

Atsushi Hiraoka;
Takashi Kumada;
Toshifumi Tada;
Kazuya Kariyama;
Joji Tani;
Shinya Fukunishi;
Masanori Atsukawa;
Masashi Hirooka;
Kunihiko Tsuji;
Toru Ishikawa;
Koichi Takaguchi;
Ei Itobayashi;
Kazuto Tajiri;
Noritomo Shimada;
Hiroshi Shibata;
Hironori Ochi;
Kazuhito Kawata;
Satoshi Yasuda;
Hidenori Toyoda;
Hideko Ohama

Publication type:

Article

Post-Progression Treatment Eligibility of Unresectable Hepatocellular Carcinoma Patients Treated with Lenvatinib.

Published in:

Liver Cancer (2235-1795), 2020, v. 9, n. 1, p. 73, doi. 10.1159/000503031

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Fukunishi, Shinya;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Tada, Toshifumi;
Toyoda, Hidenori;
Yokohama, Keisuke;
Nouso, Kazuhiro;
Tsutsui, Akemi;
Nagano, Takuya

Publication type:

Article

Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis.

Published in:

Cancer Medicine, 2019, v. 8, n. 8, p. 3719, doi. 10.1002/cam4.2241

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Tada, Toshifumi;
Toyoda, Hidenori;
Nouso, Kazuhiro;
Tsutsui, Akemi;
Nagano, Takuya;
Itokawa, Norio;
Hayama, Korenobu

Publication type:

Article

Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions: Multicenter analysis.

Published in:

Cancer Medicine, 2019, v. 8, n. 1, p. 137, doi. 10.1002/cam4.1909

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Kariyama, Kazuya;
Takaguchi, Koichi;
Atsukawa, Masanori;
Itobayashi, Ei;
Tsuji, Kunihiko;
Tajiri, Kazuto;
Hirooka, Masashi;
Shimada, Noritomo;
Shibata, Hiroshi;
Ishikawa, Toru;
Ochi, Hironori;
Tada, Toshifumi;
Toyoda, Hidenori;
Nouso, Kazuhiro;
Tsutsui, Akemi;
Itokawa, Norio;
Imai, Michitaka;
Joko, Kouji

Publication type:

Article

Geriatric nutritional risk index and newly developed scoring system as prognosis prediction for unresectable hepatocellular carcinoma patients treated with lenvatinib.

Published in:

Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-024-78539-4

By:

Ohama, Hideko;
Hiraoka, Atsushi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

Characteristics and Prognosis of Hepatocellular Carcinoma in Japanese Patients Undergoing Dialysis.

Published in:

Therapeutic Apheresis & Dialysis, 2017, v. 21, n. 5, p. 465, doi. 10.1111/1744-9987.12563

By:

Toyoda, Hidenori;
Hiraoka, Atsushi;
Tada, Toshifumi;
Michitaka, Kojiro;
Takaguchi, Koichi;
Tsuji, Kunihiko;
Itobayashi, Ei;
Takizawa, Daichi;
Hirooka, Masashi;
Koizumi, Yohei;
Ochi, Hironori;
Joko, Koji;
Kisaka, Yoshiyasu;
Shimizu, Yuko;
Tajiri, Kazuto;
Tani, Joji;
Taniguchi, Tatsuya;
Toshimori, Akiko;
Fujioka, Shinichi;
Kumada, Takashi

Publication type:

Article

Effect of Proteinuria Before Lenvatinib Administration on Treatment Response After Atezolizumab Bevacizumab Combination Therapy.

Published in:

JGH Open, 2025, v. 9, n. 1, p. 1, doi. 10.1002/jgh3.70098

By:

Ochi, Hironori;
Kurosaki, Masayuki;
Tanaka, Takaaki;
Tamaki, Nobuharu;
Tsuchiya, Kaoru;
Yasui, Yutaka;
Marusawa, Hiroyuki;
Tada, Toshifumi;
Nakamura, Shinichiro;
Akahane, Takehiro;
Okamoto, Eisuke;
Kobashi, Haruhiko;
Arai, Hirotaka;
Nonogi, Michiko;
Izumi, Namiki

Publication type:

Article

Effect of treatment periods on efficacy of glecaprevir and pibrentasvir in chronic hepatitis C: A nationwide, prospective, multicenter study.

Published in:

JGH Open, 2024, v. 8, n. 4, p. 1, doi. 10.1002/jgh3.13068

By:

Morita, Atsuhiro;
Tamaki, Nobuharu;
Kobashi, Haruhiko;
Mori, Nami;
Tsuji, Keiji;
Takaki, Shintaro;
Hasebe, Chitomi;
Akahane, Takehiro;
Ochi, Hironori;
Mashiba, Toshie;
Urawa, Naohito;
Fujii, Hideki;
Mitsuda, Akeri;
Kondo, Masahiko;
Ogawa, Chikara;
Uchida, Yasushi;
Narita, Ryoichi;
Marusawa, Hiroyuki;
Kubotsu, Yoshihito;
Matsushita, Tomomichi

Publication type:

Article

Necessity for surveillance for hepatocellualr carcinoma in older patients with chronic hepatitis C who achieved sustained virological response.

Published in:

JGH Open, 2023, v. 7, n. 6, p. 424, doi. 10.1002/jgh3.12914

By:

Ishido, Shun;
Tamaki, Nobuharu;
Kurosaki, Masayuki;
Mori, Nami;
Tsuji, Keiji;
Hasebe, Chitomi;
Mashiba, Toshie;
Ochi, Hironori;
Yasui, Yutaka;
Akahane, Takehiro;
Furuta, Koichiro;
Kobashi, Haruhiko;
Fujii, Hideki;
Ishii, Toru;
Marusawa, Hiroyuki;
Kondo, Masahiko;
Kusakabe, Atsunori;
Yoshida, Hideo;
Uchida, Yasushi;
Tada, Toshifumi

Publication type:

Article

Endoscopic Surgery under Fluoroscopic Guidance Is Useful for Diagnosing and Treating Epiphyseal Osteomyelitis Caused by Mycobacterium Species.

Published in:

2018

By:

Ochi, Hironori;
Taira, Katsuaki;
Nemoto, Naho;
Oikawa, Noboru;
Nagao, Soya;
Takano, Tadamasa;
Kaneko, Kazuo

Publication type:

Case Study

Safe and Effective Reduction Technique for Intertrochanteric Fracture with Ipsilateral Below-Knee Amputated Limb.

Published in:

Case Reports in Orthopedics, 2017, p. 1, doi. 10.1155/2017/2672905

By:

Ochi, Hironori;
Baba, Tomonori;
Hamanaka, Takahiro;
Ozaki, Yu;
Watari, Taiji;
Homma, Yasuhiro;
Matsumoto, Mikio;
Kaneko, Kazuo

Publication type:

Article

Influence of the contralateral hip state after total hip arthroplasty on patient-reported outcomes measured with the Forgotten Joint Score-12.

Published in:

European Journal of Orthopaedic Surgery & Traumatology, 2017, v. 27, n. 7, p. 929, doi. 10.1007/s00590-017-1963-3

By:

Matsumoto, Mikio;
Baba, Tomonori;
Ochi, Hironori;
Ozaki, Yu;
Watari, Taiji;
Homma, Yasuhiro;
Kaneko, Kazuo

Publication type:

Article

Validation study of the Forgotten Joint Score-12 as a universal patient-reported outcome measure.

Published in:

European Journal of Orthopaedic Surgery & Traumatology, 2015, v. 25, n. 7, p. 1141, doi. 10.1007/s00590-015-1660-z

By:

Matsumoto, Mikio;
Baba, Tomonori;
Homma, Yasuhiro;
Kobayashi, Hideo;
Ochi, Hironori;
Yuasa, Takahito;
Behrend, Henrik;
Kaneko, Kazuo

Publication type:

Article

Therapeutic efficacy of ramucirumab after lenvatinib for post-progression treatment of unresectable hepatocellular carcinoma.

Published in:

Gastroenterology Report, 2021, v. 9, n. 2, p. 133, doi. 10.1093/gastro/goaa042

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Tada, Toshifumi;
Ogawa, Chikara;
Tani, Joji;
Fukunishi, Shinya;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Kawata, Kazuhito;
Toyoda, Hidenori;
Ohama, Hideko

Publication type:

Article

Head‐to‐Head Comparison of Long‐Term HCC Risk of Antivirals‐Treated Versus Untreated Low‐Level Viremia in HBV‐Compensated Cirrhosis.

Published in:

Journal of Gastroenterology & Hepatology, 2025, v. 40, n. 6, p. 1595, doi. 10.1111/jgh.16986

By:

Tamaki, Nobuharu;
Huang, Daniel Q.;
Lee, Hyung Woong;
Park, Soo Young;
Lee, Yu Rim;
Sinn, Dong Hyun;
Lim, Tae Seop;
Marusawa, Hiroyuki;
Lim, Seng Gee;
Ochi, Hironori;
Kondo, Masahiko;
Uchida, Yasushi;
Kobashi, Haruhiko;
Furuta, Koichiro;
Kurosaki, Masayuki;
Kim, Beom Kyung

Publication type:

Article

Impact of first‐line systemic therapy with atezolizumab plus bevacizumab in patients with hepatocellular carcinoma.

Published in:

Journal of Gastroenterology & Hepatology, 2023, v. 38, n. 8, p. 1389, doi. 10.1111/jgh.16225

By:

Tada, Toshifumi;
Kumada, Takashi;
Hiraoka, Atsushi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

Clinical importance of muscle volume in lenvatinib treatment for hepatocellular carcinoma: Analysis adjusted with inverse probability weighting.

Published in:

Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 7, p. 1812, doi. 10.1111/jgh.15336

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Kariyama, Kazuya;
Tada, Toshifumi;
Tani, Joji;
Fukunishi, Shinya;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Kawata, Kazuhito;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ohama, Hideko

Publication type:

Article

Role of severe thrombocytopenia in preventing platelet count recovery in thrombocytopenic patients with chronic liver disease.

Published in:

Journal of Gastroenterology & Hepatology, 2020, v. 35, n. 2, p. 299, doi. 10.1111/jgh.14786

By:

Hirooka, Masashi;
Ochi, Hironori;
Hiraoka, Atsushi;
Koizumi, Yohei;
Tanaka, Takaaki;
Sunago, Kotaro;
Yukimoto, Atsushi;
Imai, Yusuke;
Watanabe, Takao;
Yoshida, Osamu;
Abe, Masanori;
Joko, Kouji;
Michitaka, Kojiro;
Hiasa, Yoichi

Publication type:

Article

Impact of albumin–bilirubin grade on survival in patients with hepatocellular carcinoma who received sorafenib: An analysis using time‐dependent receiver operating characteristic.

Published in:

Journal of Gastroenterology & Hepatology, 2019, v. 34, n. 6, p. 1066, doi. 10.1111/jgh.14564

By:

Tada, Toshifumi;
Kumada, Takashi;
Toyoda, Hidenori;
Tsuji, Kunihiko;
Hiraoka, Atsushi;
Michitaka, Kojiro;
Deguchi, Akihiro;
Ishikawa, Toru;
Imai, Michitaka;
Ochi, Hironori;
Joko, Koji;
Shimada, Noritomo;
Tajiri, Kazuto;
Hirooka, Masashi;
Koizumi, Yohei;
Hiasa, Yoichi;
Tanaka, Junko

Publication type:

Article

Prospective cohort trial to confirm the efficacy of no‐touch radio frequency ablation.

Published in:

Journal of Gastroenterology & Hepatology, 2019, v. 34, n. 3, p. 567, doi. 10.1111/jgh.14476

By:

Hirooka, Masashi;
Hiraoka, Atsushi;
Ochi, Hironori;
Koizumi, Yohei;
Michitaka, Kojiro;
Joko, Kouji;
Abe, Masanori;
Hiasa, Yoichi

Publication type:

Article

Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group.

Published in:

PLoS ONE, 2018, v. 13, n. 4, p. 1, doi. 10.1371/journal.pone.0194704

By:

Mashiba, Toshie;
Joko, Kouji;
Kurosaki, Masayuki;
Ochi, Hironori;
Osaki, Yukio;
Kojima, Yuji;
Nakata, Ryo;
Goto, Tohru;
Takehiro, Akahane;
Kimura, Hiroyuki;
Mitsuda, Akeri;
Kawanami, Chiharu;
Uchida, Yasushi;
Ogawa, Chikara;
Kusakabe, Atsunori;
Narita, Ryuichi;
Ide, Yasushi;
Abe, Takehiko;
Tsuji, Keiji;
Kitamura, Tadashi

Publication type:

Article

Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis.

Published in:

Digestive Diseases, 2017, v. 35, n. 6, p. 602, doi. 10.1159/000480256

By:

Atsushi Hiraoka;
Takashi Kumada;
Masatoshi Kudo;
Masashi Hirooka;
Yohei Koizumi;
Yoichi Hiasa;
Kazuto Tajiri;
Hidenori Toyoda;
Toshifumi Tada;
Hironori Ochi;
Koji Joko;
Noritomo Shimada;
Akihiro Deguchi;
Toru Ishikawa;
Michitaka Imai;
Kunihiko Tsuji;
Kojiro Michitaka

Publication type:

Article

Hypovascular Hepatic Nodules Showing Hypointense on the Hepatobiliary-Phase Image of Gd-EOB-DTPA-Enhanced MRI to Develop a Hypervascular Hepatocellular Carcinoma: A Nationwide Retrospective Study on Their Natural Course and Risk Factors.

Published in:

Digestive Diseases, 2013, v. 31, n. 5/6, p. 472, doi. 10.1159/000355248

By:

Inoue, Tatsuo;
Hyodo, Tomoko;
Murakami, Takamichi;
Takayama, Yukihisa;
Nishie, akihiro;
Higaki, atsushi;
Korenaga, Keiko;
Sakamoto, azusa;
Osaki, Yukio;
aikata, Hiroshi;
Chayama, Kazuaki;
Suda, Takeshi;
Takano, Toru;
Miyoshi, Kennichi;
Koda, Masahiko;
Numata, Kazushi;
Tanaka, Hironori;
Iijima, Hiroko;
Ochi, Hironori;
Hirooka, Masashi

Publication type:

Article

Acetabular cartilage abnormalities in elderly patients with femoral neck fractures.

Published in:

SICOT-J, 2022, v. 8, p. 1, doi. 10.1051/sicotj/2022022

By:

Ochi, Hironori;
Kobayashi, Hideo;
Baba, Tomonori;
Nakajima, Riko;
Kurita, Yasuha;
Kato, Suguru;
Sasaki, Kyoko;
Nozawa, Masahiko;
Kim, Sung-Gon;
Sakamoto, Yuko;
Homma, Yasuhiro;
Kaneko, Kazuo;
Ishijima, Muneaki

Publication type:

Article

Plate coverage predicts failure for volarly unstable distal radius fractures with volar lunate facet fragments.

Published in:

SICOT-J, 2020, v. 6, p. 1, doi. 10.1051/sicotj/2020026

By:

Yuta Izawa;
Yoshihiko Tsuchida;
Kentaro Futamura;
Hironori Ochi;
Tomonori Baba

Publication type:

Article

Efficacy of hepatitis C virus eradication after curative treatment for hepatocellular carcinoma in patients with advanced hepatocellular carcinoma and decreased hepatic functional reserve: A nationwide, multicentre study by the Japanese Red Cross Liver Study Group

Published in:

Journal of Viral Hepatitis, 2022, v. 29, n. 7, p. 551, doi. 10.1111/jvh.13684

By:

Mashiba, Toshie;
Joko, Kouji;
Kurosaki, Masayuki;
Ochi, Hironori;
Marusawa, Hiroyuki;
Uchida, Yasushi;
Fujii, Hideki;
Kojima, Yuji;
Yoshida, Hideo;
Goto, Tohru;
Akahane, Takehiro;
Kondo, Masahiko;
Tsuji, Keiji;
Mitsuda, Akeri;
Hasebe, Chitomi;
Kusakabe, Atsunori;
Sohda, Tetsuro;
Furuta, Koichiro;
Kobashi, Haruhiko;
Ogawa, Chikara

Publication type:

Article

Total Hip Arthroplasty for Implant Rupture after Surgery for Atypical Subtrochanteric Femoral Fracture.

Published in:

2016

By:

Ozaki, Yu;
Baba, Tomonori;
Ochi, Hironori;
Homma, Yasuhiro;
Watari, Taiji;
Matsumoto, Mikio;
Kaneko, Kazuo

Publication type:

Case Study

Rapid Hip Osteoarthritis Development in a Patient with Anterior Acetabular Cyst with Sagittal Alignment Change.

Published in:

Case Reports in Orthopedics, 2014, p. 1, doi. 10.1155/2014/523426

By:

Yasuhiro Homma;
Tomonori Baba;
Nobuhiko Sumiyoshi;
Hironori Ochi;
Hideo Kobayashi;
Mikio Matsumoto;
Takahito Yuasa;
Kazuo Kaneko

Publication type:

Article

Lenvatinib-induced thyroid abnormalities in unresectable hepatocellular carcinoma.

Published in:

Endocrine Journal, 2019, v. 66, n. 9, p. 787, doi. 10.1507/endocrj.ej19-0140

By:

Yohei Koizumi;
Masashi Hirooka;
Atsushi Hiraoka;
Hironori Ochi;
Takaaki Tanaka;
Atsushi Yukimoto;
Yuusuke Imai;
Takao Watanabe;
Osamu Yoshida;
Teruki Miyake;
Bunzo Matsuura;
Kojiro Michitaka;
Kouji Joko;
Masanori Abe;
Yoichi Hiasa

Publication type:

Article

Treatment response to durvalumab plus tremelimumab after progression with previous immune checkpoint inhibitor in unresectable hepatocellular carcinoma.

Published in:

Investigational New Drugs, 2024, v. 42, n. 5, p. 559, doi. 10.1007/s10637-024-01470-y

By:

Mori, Nami;
Tamaki, Nobuharu;
Takaki, Shintaro;
Tsuji, Keiji;
Tada, Toshifumi;
Nakamura, Shinichiro;
Ochi, Hironori;
Mashiba, Toshie;
Doisaki, Masao;
Marusawa, Hiroyuki;
Kobashi, Haruhiko;
Fujii, Hideki;
Ogawa, Chikara;
Nonogi, Michiko;
Arai, Hirotaka;
Uchida, Yasushi;
Urawa, Naohito;
Narita, Ryoichi;
Akahane, Takehiro;
Kondo, Masahiko

Publication type:

Article

Effects on survival of the adverse event of atezolizumab plus bevacizumab for hepatocellular carcinoma: a multicenter study by the Japan Red Cross Liver Study Group.

Published in:

Investigational New Drugs, 2023, v. 41, n. 2, p. 340, doi. 10.1007/s10637-023-01349-4

By:

Takaki, Shintaro;
Kurosaki, Masayuki;
Mori, Nami;
Tsuji, Keiji;
Ochi, Hironori;
Marusawa, Hiroyuki;
Nakamura, Shinichiro;
Tada, Toshifumi;
Narita, Ryoichi;
Uchida, Yasushi;
Akahane, Takehiro;
Kondo, Masahiko;
Kusakabe, Atsunori;
Furuta, Koichiro;
Kobashi, Haruhiko;
Arai, Hirotaka;
Nonogi, Michiko;
Tamada, Takashi;
Hasebe, Chitomi;
Ogawa, Chikara

Publication type:

Article

Optimal threshold of alpha-fetoprotein response in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab.

Published in:

Investigational New Drugs, 2022, v. 40, n. 6, p. 1290, doi. 10.1007/s10637-022-01303-w

By:

Tamaki, Nobuharu;
Tada, Toshifumi;
Kurosaki, Masayuki;
Yasui, Yutaka;
Ochi, Hironori;
Mashiba, Toshie;
Sakamoto, Azusa;
Marusawa, Hiroyuki;
Narita, Ryoichi;
Uchida, Yasushi;
Akahane, Takehiro;
Kondo, Masahiko;
Mori, Nami;
Takaki, Shintaro;
Tsuji, Keiji;
Kobashi, Haruhiko;
Kusakabe, Atsunori;
Furuta, Koichiro;
Arai, Hirotaka;
Nonogi, Michiko

Publication type:

Article

Importance of the spinopelvic factors on the pelvic inclination from standing to sitting before total hip arthroplasty.

Published in:

2016

By:

Ochi, Hironori;
Baba, Tomonori;
Homma, Yasuhiro;
Matsumoto, Mikio;
Nojiri, Hidetoshi;
Kaneko, Kazuo

Publication type:

journal article

Comparing the impact of atezolizumab plus bevacizumab and lenvatinib on the liver function in hepatocellular carcinoma patients: A mixed‐effects regression model approach.

Published in:

Cancer Medicine, 2023, v. 12, n. 24, p. 21680, doi. 10.1002/cam4.6726

By:

Hatanaka, Takeshi;
Kakizaki, Satoru;
Hiraoka, Atsushi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Yokohama, Keisuke;
Nishikawa, Hiroki

Publication type:

Article

Adverse events as potential predictive factors of therapeutic activity in patients with unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab.

Published in:

Cancer Medicine, 2023, v. 12, n. 7, p. 7772, doi. 10.1002/cam4.5535

By:

Tada, Toshifumi;
Kumada, Takashi;
Hiraoka, Atsushi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

New prognostic system based on inflammation and liver function predicts prognosis in patients with advanced unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab: A validation study.

Published in:

Cancer Medicine, 2023, v. 12, n. 6, p. 6980, doi. 10.1002/cam4.5495

By:

Tada, Toshifumi;
Kumada, Takashi;
Hiraoka, Atsushi;
Kariyama, Kazuya;
Tani, Joji;
Hirooka, Masashi;
Takaguchi, Koichi;
Atsukawa, Masanori;
Fukunishi, Shinya;
Itobayashi, Ei;
Tsuji, Kunihiko;
Tajiri, Kazuto;
Ochi, Hironori;
Ishikawa, Toru;
Yasuda, Satoshi;
Ogawa, Chikara;
Toyoda, Hidenori;
Hatanaka, Takeshi;
Nishimura, Takashi;
Kakizaki, Satoru

Publication type:

Article

Comparative efficacy and safety of atezolizumab and bevacizumab between hepatocellular carcinoma patients with viral and non‐viral infection: A Japanese multicenter observational study.

Published in:

Cancer Medicine, 2023, v. 12, n. 5, p. 5293, doi. 10.1002/cam4.5337

By:

Hatanaka, Takeshi;
Kakizaki, Satoru;
Hiraoka, Atsushi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Shimada, Noritomo

Publication type:

Article